ArticleKidney international reports2026
Response to the Letter to the Editor Entitled "Reconsideration of Response Assessment in Obinutuzumab-Treated Membranous Nephropathy".
Xiaole Su et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.